NASDAQ : JANX

Janux Therapeutics, Inc.

$16.24 USD

$0.4 (2.53%)

Volume
277.78K
Average Volume
1.13M
Market Capitalization
$990.39M
P/E Ratio
-8.83
Dividend Yield
0.00%
Price Target
$22.00
Year High
$35.34
Year Low
$12.12
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$17.01
JANX vs. The Competition
Properties JANX ABCL BHVN CLDX
Market Cap $990.39M $1.98B $1.62B $2.37B
Shares Outstanding $60.98M $305.38M $105.87M $66.54M
P/E Ratio -8.83 -13.51 -2.7 -8.34
EPS -1.83 -0.47 -4.39 -4.26
Day Low 15.65 5.93 13.62 34.37
Day High 16.385 6.545 15.38 36.04
Year Low 12.12 2.745 7.48 19.72
Year High 35.34 8.44 18.566 40.3
Average Price 50 14.604 5.8588 12.2262 33.2978
Average Price 200 17.31643 4.4837 11.6438 29.11825
Volume 277.78K 3.18M 1.67M 596.78K
Average Volume - - - -
JANX Top Competitors
Symbol Name Last Change %Chg Volume
ABCL AbCellera Biologics Inc. $6.485 0.325 5.28% 3.18M
BHVN Biohaven Ltd. $15.3 1.13 7.97% 1.67M
CLDX Celldex Therapeutics, Inc. $35.61 0.21 0.59% 596.78K